Foresite Capital Opportunity Management V, LLC

10% Owner
Foresite Capital Opportunity Management V, LLC
$16,857,000.00
%
COMPANY
SHARES
NET TOTAL
24.43%
Compass Therapeutics, Inc.
1,554,250
$4,119,000.00
24.41%
Gemini Therapeutics, Inc.
2,435,125
$4,115,000.00
21.82%
Kinnate Biopharma Inc.
291,667
$3,678,000.00
14.72%
Adicet Bio, Inc.
170,000
$2,482,000.00
8.23%
Hims & Hers Health, Inc.
306,431
$1,388,000.00
6.38%
Enanta Pharmaceuticals, Inc.
22,750
$1,075,000.00